1. Home
  2. LAC vs NVCR Comparison

LAC vs NVCR Comparison

Compare LAC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lithium Americas Corp.

LAC

Lithium Americas Corp.

HOLD

Current Price

$5.03

Market Cap

1.4B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$11.74

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAC
NVCR
Founded
2023
2000
Country
Canada
Switzerland
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
LAC
NVCR
Price
$5.03
$11.74
Analyst Decision
Hold
Buy
Analyst Count
6
6
Target Price
$6.17
$27.75
AVG Volume (30 Days)
11.3M
2.2M
Earning Date
01-01-0001
04-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$605,220,000.00
Revenue This Year
N/A
$10.50
Revenue Next Year
N/A
$4.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.82
52 Week Low
$2.31
$9.82
52 Week High
$10.52
$22.29

Technical Indicators

Market Signals
Indicator
LAC
NVCR
Relative Strength Index (RSI) 46.79 44.15
Support Level $4.37 $10.86
Resistance Level $5.43 $13.78
Average True Range (ATR) 0.27 0.86
MACD -0.01 0.06
Stochastic Oscillator 47.19 25.83

Price Performance

Historical Comparison
LAC
NVCR

About LAC Lithium Americas Corp.

Lithium Americas is a pure-play lithium producer. Following a deal with the US government, the firm will own 59% of one resource, Thacker Pass, which is located in northwest Nevada, with automaker General Motors owning 36% and the US government owning 5%. Thacker Pass is under construction and expected to begin production in 2028. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: